Pulmonary Hypertension Archive

A building with a stone facade displays a sign that reads
Tabitha G. Moe, M.D. FACC
A building with a stone facade displays a sign that reads
PHASE 1B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF COR-1389 ON CARDIOPULMONARY HEMODYNAMICS IN PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH LEFT-HEART DISEASE (PH-LHD)
A building with a stone facade displays a sign that reads
A Phase 2, Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of TX000045 After 24 Weeks of Treatment in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (PH-HFpEF)
A building with a stone facade displays a sign that reads
A Phase 2, Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of TX000045 After 24 Weeks of Treatment in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (PH-HFpEF)